103 Shares in Axon Enterprise, Inc. (NASDAQ:AXON) Acquired by Brooklyn Investment Group

Brooklyn Investment Group purchased a new position in shares of Axon Enterprise, Inc. (NASDAQ:AXON) during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 103 shares of the biotechnology company’s stock, valued at approximately $41,000.

Several other hedge funds and other institutional investors have also recently bought and sold shares of AXON. Tidal Investments LLC lifted its position in Axon Enterprise by 22.4% during the 1st quarter. Tidal Investments LLC now owns 4,833 shares of the biotechnology company’s stock worth $1,512,000 after acquiring an additional 884 shares in the last quarter. Cetera Investment Advisers increased its holdings in Axon Enterprise by 280.6% during the 1st quarter. Cetera Investment Advisers now owns 21,067 shares of the biotechnology company’s stock worth $6,592,000 after purchasing an additional 15,532 shares during the last quarter. Cetera Advisors LLC increased its holdings in Axon Enterprise by 49.7% during the 1st quarter. Cetera Advisors LLC now owns 7,623 shares of the biotechnology company’s stock worth $2,385,000 after purchasing an additional 2,532 shares during the last quarter. DekaBank Deutsche Girozentrale increased its holdings in Axon Enterprise by 45.4% during the 1st quarter. DekaBank Deutsche Girozentrale now owns 16,986 shares of the biotechnology company’s stock worth $5,321,000 after purchasing an additional 5,301 shares during the last quarter. Finally, Transcend Capital Advisors LLC purchased a new stake in Axon Enterprise during the 2nd quarter worth approximately $206,000. 79.08% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other news, CFO Brittany Bagley sold 4,338 shares of the stock in a transaction on Thursday, September 12th. The stock was sold at an average price of $378.95, for a total value of $1,643,885.10. Following the completion of the transaction, the chief financial officer now owns 98,825 shares of the company’s stock, valued at approximately $37,449,733.75. This represents a 4.20 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, CEO Patrick W. Smith sold 75,000 shares of the stock in a transaction on Tuesday, September 3rd. The stock was sold at an average price of $356.53, for a total value of $26,739,750.00. Following the completion of the transaction, the chief executive officer now directly owns 2,970,366 shares of the company’s stock, valued at approximately $1,059,024,589.98. The trade was a 2.46 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 210,256 shares of company stock valued at $87,783,120 over the last three months. Company insiders own 6.10% of the company’s stock.

Analyst Ratings Changes

Several research firms have issued reports on AXON. Barclays lifted their price objective on Axon Enterprise from $381.00 to $387.00 and gave the stock an “overweight” rating in a report on Wednesday, August 7th. Needham & Company LLC lifted their price objective on Axon Enterprise from $525.00 to $600.00 and gave the stock a “buy” rating in a report on Friday, November 8th. The Goldman Sachs Group lifted their price objective on Axon Enterprise from $385.00 to $441.00 and gave the stock a “buy” rating in a report on Wednesday, October 23rd. Robert W. Baird lifted their price objective on Axon Enterprise from $440.00 to $460.00 and gave the stock an “outperform” rating in a report on Monday, November 4th. Finally, Craig Hallum lifted their price objective on Axon Enterprise from $370.00 to $376.00 and gave the stock a “buy” rating in a report on Wednesday, August 7th. Two research analysts have rated the stock with a hold rating and twelve have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $427.83.

Axon Enterprise Price Performance

Shares of NASDAQ AXON opened at $646.96 on Friday. Axon Enterprise, Inc. has a 1-year low of $224.28 and a 1-year high of $652.22. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.96 and a quick ratio of 2.63. The business’s fifty day moving average price is $483.18 and its two-hundred day moving average price is $376.61. The firm has a market capitalization of $49.33 billion, a PE ratio of 167.17, a P/E/G ratio of 13.97 and a beta of 0.94.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.